Page 110 - Genomic Medicine in Emerging Economies

References 99

Strate, L.L., Syngal, S., 2005. Hereditary colorectal cancer syndromes. Cancer Causes Control 16,
201–213.
Theodoratou, E., Campbell, H., Tenesa, A., Houlston, R., Webb, E., Lubbe, S., et al., 2010. A large-
scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants.
Br. J. Cancer 103 (12), 1875–1884.
Thompson, B.A., Spurdle, A.B., Plazzer, J.-P., Greenblatt, M.S., Akagi, K., Al-Mulla, F., et al., 2014.
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch
repair gene variants in the InSiGHT locus-specific database. Nat. Genet. 46 (2), 107–115.
Tiwari, A.K., Roy, H.K., Lynch, H.T., 2016. Lynch syndrome in the 21st century: clinical perspec-
tives. QJM 109 (3), 151–158.
Torres, D., Rashid, M.U., Gil, F., Umana, A., Ramelli, G., Robledo, J.F., et al., 2007. High proportion
of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
Breast Cancer Res. Treat. 103 (2), 225–232.
Torres-Mejia, G., Royer, R., Llacuachaqui, M., Akbari, M.R., Giuliano, a.R., Martinez-Matsushita,
L., et al., 2015. Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.
Cancer Epidemiol. Biomarkers Prev. 24 (3), 498–505.
Torrezan, G.T., da Silva, F.C.C., Santos, E.M.M., Krepischi, A.C.V., Achatz, M.I.W., Aguiar, S., et al.,
2013. Mutational spectrum of the APC and MUTYH genes and genotype-phenotype correla-
tions in Brazilian FAP, AFAP, and MAP patients. Orphanet J. Rare Dis. 8, 54.
Umar, A., Boland, C.R., Terdiman, J.P., Syngal, S., de la Chapelle, A., Rüschoff, J., et al., 2004.
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome)
and microsatellite instability. J. Natl. Cancer Inst. 96 (4), 261–268.
Vaca-Paniagua, F., Alvarez-Gomez, R.M., Fragoso-Ontiveros, V., Vidal-Millan, S., Herrera, L.A.,
Cantú, D., et al., 2012. Full-Exon pyrosequencing screening of BRCA germline mutations in
Mexican women with inherited breast and ovarian cancer. PLoS One 7 (5).
Vaccaro, C.A., Bonadeo, F., Roverano, A.V., Peltomaki, P., Bala, S., Renkonen, E., et al., 2007a.
Hereditary nonpolyposis colorectal cancer (Lynch syndrome) in Argentina: report from a
referral hospital register. Dis. Colon Rectum 50 (10), 1604–1611.
Vaccaro, C.A., Carrozzo, J.E., Mocetti, E., Berho, M., Valdemoros, P., Mullen, E., et al., 2007b.
Immunohistochemical expression and microsatellite instability in Lynch syndrome. Medicina
(B Aires) 67 (3), 274–278.
Vaccaro, C.A., Sarroca, C., Rossi, B., Lopez-Kostner, F., Dominguez, M., Calo, N.C., et al., 2016.
Lynch syndrome in South America: past, present and future. Fam. Cancer 15 (3), 437–445.
Valentin, M.D., Da Silva, F.C., Santos, E.M.M., Dos, Lisboa, B.G., De Oliveira, L.P., De Oliveira
Ferreira, F., et al., 2011. Characterization of germline mutations of MLH1 and MSH2 in
unrelated south American suspected Lynch syndrome individuals. Fam. Cancer 10 (4),
641–647.
Valentin, M.D., Da Silva, F.C., Santos, E.M.M., Da Silva, S.D., De Oliveira Ferreira, F., Aguiar, S.,
et al., 2012. Evaluation of MLH1 I219V polymorphism in unrelated South American individu-
als suspected of having Lynch syndrome. Anticancer Res. 32 (10), 4347–4352.
Vasen, H.F., Muller, H., 1991. DNA studies in families with hereditary forms of cancer. Ned Tijdschr
Geneeskd. 135 (36), 1620–1623.
Vasen, H.F.A., Watson, P., Mecklin, J.P., Lynch, H.T., 1999. New clinical criteria for hereditary non-
polyposis colorectal cancer (HNPCCLynch syndrome) proposed by the International Collab-
orative Group on HNPCC. Gastroenterology, 1453–1456.
Viana, D.V., Góes, J.R.N., Coy, C.S.R., De Lourdes Setsuko Ayrizono, M., Lima, C.S.P., Lopes-
Cendes, I., 2008. Family history of cancer in Brazil: Is it being used? Fam. Cancer 7 (3),
229–232.